STOCK TITAN

Warby Parker insider files Form 144 for 50,000 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Warby Parker Inc. (WRBY) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,350,500 and an approximate sale date of 09/11/2025. The shares were acquired on 06/28/2017 via previously exercised stock options. The filing reports 105,187,778 shares outstanding. The document also discloses three Rule 10b5-1 sales attributed to David Gilboa in the past three months: 74,500 shares on 07/21/2025 for $1,808,047.95, 500 shares on 07/18/2025 for $12,006.00, and 50,000 shares on 07/01/2025 for $1,101,870.00. The filer certifies absence of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Insiders disclosed structured sales; transactions are routine and documented under Rule 144/10b5-1.

The filing documents a proposed Rule 144 sale of 50,000 WRBY shares and recent 10b5-1 plan sales by David Gilboa totaling 125,000 shares over the past three months. The shares to be sold were acquired via option exercise in 2017, indicating these are vested, non-restricted shares. The use of a broker and the 10b5-1 framework signals planned, pre-arranged disposals rather than opportunistic trades. Relative to the 105.2 million shares outstanding, the disclosed quantities are small in percentage terms, suggesting limited immediate market impact absent other disclosures.

TL;DR: Disclosure aligns with regulatory requirements; representation of no undisclosed material information is standard.

The form includes the required certification that the seller is not aware of any undisclosed material adverse information and notes adoption/usage of 10b5-1 sales plans. The filing provides acquisition details (06/28/2017) and payment information, fulfilling transparency expectations for insider dispositions. There are no statements of new governance actions, litigation, or other corporate events in this notice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the WRBY Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 50,000 common shares via Morgan Stanley Smith Barney valued at $1,350,500 with an approximate sale date of 09/11/2025.

When and how were the shares to be sold acquired?

The 50,000 shares were acquired on 06/28/2017 through previously exercised stock options and were paid for on that date.

Are there recent insider sales disclosed for WRBY?

Yes. The filing reports 10b5-1 sales by David Gilboa totaling 125,000 shares in the past three months: 50,000 on 07/01/2025, 500 on 07/18/2025, and 74,500 on 07/21/2025.

How many WRBY shares are outstanding according to the filing?

The filing reports 105,187,778 shares outstanding.

Does the filer represent any undisclosed material information?

By signing the notice, the person represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.
Warby Parker Inc

NYSE:WRBY

WRBY Rankings

WRBY Latest News

WRBY Latest SEC Filings

WRBY Stock Data

2.95B
97.87M
7.51%
95.76%
7.49%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
NEW YORK